Dr.SurgeonPGH said:Orforglipron is the more interesting oral story because it is not a peptide at all.
Thank you for spelling out the reasoning rather than just the conclusion. I will report back once I have actually tried it.
Dr.SurgeonPGH said:Orforglipron is the more interesting oral story because it is not a peptide at all.
Thank you for spelling out the reasoning rather than just the conclusion. I will report back once I have actually tried it.
Clinical perspective, offered as context rather than as advice. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.
TinaHashiRN said:It helps to say which part of this you are uncertain about.
Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. This treats a plausible mechanism as a demonstrated one. Plausible is where you start looking, not where you stop.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsThe figures, for anyone assembling their own picture. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.
Ask again with the specifics and you will get a better answer than this one.
Moderator note: the sourcing question belongs in the vendor section and has been split out. Thread quality here is what the rules are for. Keep it up.